Co-Delivery of Curcumin and Cisplatin to Enhance Cytotoxicity of Cisplatin Using Lipid-Chitosan Hybrid Nanoparticles

Muhammad Muzamil Khan,1 Asadullah Madni,1 Nayab Tahir,2 Farzana Parveen,1 Safiullah Khan,1 Nasrullah Jan,1 Ahsan Ali,1 Muhammad Abdurrahim,1 Umar Farooq,3 Muhammad Imran Khan4 1Department of Pharmacy, The Islamia University of Bahawalpur, Bahawalpur, Pakistan; 2College of Pharmacy, University of Sar...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Khan MM, Madni A, Tahir N, Parveen F, Khan S, Jan N, Ali A, Abdurrahim M, Farooq U, Khan MI
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2020
Materias:	co-delivery chemosensitization curcumin cisplatin enhanced therapeutic output Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/8b573562ce534c9c8190ec4900e95033
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:8b573562ce534c9c8190ec4900e95033
record_format	dspace
spelling	oai:doaj.org-article:8b573562ce534c9c8190ec4900e950332021-12-02T08:50:16ZCo-Delivery of Curcumin and Cisplatin to Enhance Cytotoxicity of Cisplatin Using Lipid-Chitosan Hybrid Nanoparticles1178-2013https://doaj.org/article/8b573562ce534c9c8190ec4900e950332020-03-01T00:00:00Zhttps://www.dovepress.com/co-delivery-of-curcumin-and-cisplatin-to-enhance-cytotoxicity-of-cispl-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Muhammad Muzamil Khan,1 Asadullah Madni,1 Nayab Tahir,2 Farzana Parveen,1 Safiullah Khan,1 Nasrullah Jan,1 Ahsan Ali,1 Muhammad Abdurrahim,1 Umar Farooq,3 Muhammad Imran Khan4 1Department of Pharmacy, The Islamia University of Bahawalpur, Bahawalpur, Pakistan; 2College of Pharmacy, University of Sargodha, Sargodha, Pakistan; 3Department of Pharmacy, Government College University Faisalabad, Faisalabad, Pakistan; 4Faculty of Pharmacy, Riphah International University, Lahore, PakistanCorrespondence: Muhammad Muzamil KhanThe Islamia University of Bahawalpur, Bahawalpur, Punjab 63100, PakistanEmail muzamilpharmacist@gmail.comAsadullah MadniDepartment of Pharmacy, The Islamia University of Bahawalpur, Bahawalpur, Punjab 63100, PakistanTel +923366248108Email asadpharmacist@hotmail.comBackground: Lipid-polymer hybrid nanoparticles (LPHNP) are suitable for co-delivery of hydrophilic and lipophilic drugs. The structural advantages of polymers and biomimetic properties of lipids enable higher encapsulation of drugs and controlled release profile. Lipid-polymer hybrid nanoparticles have been prepared for co-delivery of curcumin and cisplatin for enhanced cytotoxicity against ovarian cancer.Material and Methods: Chitosan, cisplatin, curcumin, Lipoid S75 were selected as structural components and ionic gelation method was used for preparation of LPHNPs. Nanoparticles were formed via ionic interaction of positively charged chitosan and negatively charged lipid.Results: The optimized nanoparticles were of 225 nm with cationic charge. The encapsulation efficiency was greater than 80% with good drug loading. The drug release profile showed controlled release behavior of both curcumin and cisplatin simultaneously and the absence of burst release. The in vitro therapeutic efficacy and cellular association was evaluated using A2780 ovarian cell lines. To further investigate therapeutic efficacy, we developed 3D spheroids as tumor model to mimic the in vivo conditions. The cytotoxicity and uptake of co-loaded LPHNPs were evaluated on 3D spheroids and results indicated increased chemosensitization and enhanced therapeutic efficacy of co-loaded LPHNPs.Conclusion: Lipid-polymer hybrid nanoparticles could be a suitable platform for co-delivery of curcumin and cisplatin for enhanced cytotoxic effect on ovarian cell lines.Keywords: co-delivery, chemosensitization, curcumin, cisplatin, enhanced therapeutic outputKhan MMMadni ATahir NParveen FKhan SJan NAli AAbdurrahim MFarooq UKhan MIDove Medical Pressarticleco-deliverychemosensitizationcurcumincisplatinenhanced therapeutic outputMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 15, Pp 2207-2217 (2020)
institution	DOAJ
collection	DOAJ
language	EN
topic	co-delivery chemosensitization curcumin cisplatin enhanced therapeutic output Medicine (General) R5-920
spellingShingle	co-delivery chemosensitization curcumin cisplatin enhanced therapeutic output Medicine (General) R5-920 Khan MM Madni A Tahir N Parveen F Khan S Jan N Ali A Abdurrahim M Farooq U Khan MI Co-Delivery of Curcumin and Cisplatin to Enhance Cytotoxicity of Cisplatin Using Lipid-Chitosan Hybrid Nanoparticles
description	Muhammad Muzamil Khan,1 Asadullah Madni,1 Nayab Tahir,2 Farzana Parveen,1 Safiullah Khan,1 Nasrullah Jan,1 Ahsan Ali,1 Muhammad Abdurrahim,1 Umar Farooq,3 Muhammad Imran Khan4 1Department of Pharmacy, The Islamia University of Bahawalpur, Bahawalpur, Pakistan; 2College of Pharmacy, University of Sargodha, Sargodha, Pakistan; 3Department of Pharmacy, Government College University Faisalabad, Faisalabad, Pakistan; 4Faculty of Pharmacy, Riphah International University, Lahore, PakistanCorrespondence: Muhammad Muzamil KhanThe Islamia University of Bahawalpur, Bahawalpur, Punjab 63100, PakistanEmail muzamilpharmacist@gmail.comAsadullah MadniDepartment of Pharmacy, The Islamia University of Bahawalpur, Bahawalpur, Punjab 63100, PakistanTel +923366248108Email asadpharmacist@hotmail.comBackground: Lipid-polymer hybrid nanoparticles (LPHNP) are suitable for co-delivery of hydrophilic and lipophilic drugs. The structural advantages of polymers and biomimetic properties of lipids enable higher encapsulation of drugs and controlled release profile. Lipid-polymer hybrid nanoparticles have been prepared for co-delivery of curcumin and cisplatin for enhanced cytotoxicity against ovarian cancer.Material and Methods: Chitosan, cisplatin, curcumin, Lipoid S75 were selected as structural components and ionic gelation method was used for preparation of LPHNPs. Nanoparticles were formed via ionic interaction of positively charged chitosan and negatively charged lipid.Results: The optimized nanoparticles were of 225 nm with cationic charge. The encapsulation efficiency was greater than 80% with good drug loading. The drug release profile showed controlled release behavior of both curcumin and cisplatin simultaneously and the absence of burst release. The in vitro therapeutic efficacy and cellular association was evaluated using A2780 ovarian cell lines. To further investigate therapeutic efficacy, we developed 3D spheroids as tumor model to mimic the in vivo conditions. The cytotoxicity and uptake of co-loaded LPHNPs were evaluated on 3D spheroids and results indicated increased chemosensitization and enhanced therapeutic efficacy of co-loaded LPHNPs.Conclusion: Lipid-polymer hybrid nanoparticles could be a suitable platform for co-delivery of curcumin and cisplatin for enhanced cytotoxic effect on ovarian cell lines.Keywords: co-delivery, chemosensitization, curcumin, cisplatin, enhanced therapeutic output
format	article
author	Khan MM Madni A Tahir N Parveen F Khan S Jan N Ali A Abdurrahim M Farooq U Khan MI
author_facet	Khan MM Madni A Tahir N Parveen F Khan S Jan N Ali A Abdurrahim M Farooq U Khan MI
author_sort	Khan MM
title	Co-Delivery of Curcumin and Cisplatin to Enhance Cytotoxicity of Cisplatin Using Lipid-Chitosan Hybrid Nanoparticles
title_short	Co-Delivery of Curcumin and Cisplatin to Enhance Cytotoxicity of Cisplatin Using Lipid-Chitosan Hybrid Nanoparticles
title_full	Co-Delivery of Curcumin and Cisplatin to Enhance Cytotoxicity of Cisplatin Using Lipid-Chitosan Hybrid Nanoparticles
title_fullStr	Co-Delivery of Curcumin and Cisplatin to Enhance Cytotoxicity of Cisplatin Using Lipid-Chitosan Hybrid Nanoparticles
title_full_unstemmed	Co-Delivery of Curcumin and Cisplatin to Enhance Cytotoxicity of Cisplatin Using Lipid-Chitosan Hybrid Nanoparticles
title_sort	co-delivery of curcumin and cisplatin to enhance cytotoxicity of cisplatin using lipid-chitosan hybrid nanoparticles
publisher	Dove Medical Press
publishDate	2020
url	https://doaj.org/article/8b573562ce534c9c8190ec4900e95033
work_keys_str_mv	AT khanmm codeliveryofcurcuminandcisplatintoenhancecytotoxicityofcisplatinusinglipidchitosanhybridnanoparticles AT madnia codeliveryofcurcuminandcisplatintoenhancecytotoxicityofcisplatinusinglipidchitosanhybridnanoparticles AT tahirn codeliveryofcurcuminandcisplatintoenhancecytotoxicityofcisplatinusinglipidchitosanhybridnanoparticles AT parveenf codeliveryofcurcuminandcisplatintoenhancecytotoxicityofcisplatinusinglipidchitosanhybridnanoparticles AT khans codeliveryofcurcuminandcisplatintoenhancecytotoxicityofcisplatinusinglipidchitosanhybridnanoparticles AT jann codeliveryofcurcuminandcisplatintoenhancecytotoxicityofcisplatinusinglipidchitosanhybridnanoparticles AT alia codeliveryofcurcuminandcisplatintoenhancecytotoxicityofcisplatinusinglipidchitosanhybridnanoparticles AT abdurrahimm codeliveryofcurcuminandcisplatintoenhancecytotoxicityofcisplatinusinglipidchitosanhybridnanoparticles AT farooqu codeliveryofcurcuminandcisplatintoenhancecytotoxicityofcisplatinusinglipidchitosanhybridnanoparticles AT khanmi codeliveryofcurcuminandcisplatintoenhancecytotoxicityofcisplatinusinglipidchitosanhybridnanoparticles
_version_	1718398375476330496

Co-Delivery of Curcumin and Cisplatin to Enhance Cytotoxicity of Cisplatin Using Lipid-Chitosan Hybrid Nanoparticles

Ejemplares similares